Back to top

The technical outlook for NAMS is unchanged after it falls 1.06% on August 3

NewAmsterdam Pharma Company N.V. (NAMS) — SwingTradeBot Technical Analysis Report · Aug 3, 2026, 17:44 ET
NAMS posted a 1.06% loss on Monday, August 3rd, accompanied by 0.3× normal trading volume. Key support levels exist at 26.78, 26.07 & 25.21, with resistance at 28.35, 29.21 & 29.92. Slow Stochastic readings suggest the stock is currently oversold.

Current SwingTradeBot Technical Rating of NAMS: F

Is this the only signal? Not even close. Explore the full breakdown at SwingTradeBot.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NewAmsterdam Pharma Company N.V. (NAMS)